Metabolic Dysfunction-Associated Steatotic Liver Disease

• Titel: Metabolic Dysfunction-Associated Steatotic Liver Disease
• Titelzusatz: Prevalence, research insights and the future directions
• Mitwirkende: Méndez-Sánchez, Nahum [HerausgeberIn]
• Mitwirkende: Qi, Xingshun [HerausgeberIn]
• Verf.angabe: edited by Nahum Méndez-Sánchez, Xingshun Qi
• Ausgabe: 1st ed. 2024.
• Verlagsort: Singapore
• Verlagsort: Singapore
• Verlag: Springer Nature Singapore
• Verlag: Imprint: Springer
• E-Jahr: 2024
• Jahr: 2024.
• Jahr: 2024.
• Umfang: 1 Online-Ressource(VIII, 170 p. 26 illus., 25 illus. in color.)
• ISBN: 978-981-9795-19-2
• DOI: doi:10.1007/978-981-97-9519-2
• Datenträger: Online-Ressource
• Sprache: eng
• Bibliogr. Hinweis: Erscheint auch als : Druck-Ausgabe
• Bibliogr. Hinweis: Erscheint auch als : Druck-Ausgabe
• Bibliogr. Hinweis: Erscheint auch als : Druck-Ausgabe
• K10plus-PPN: 1913639479
• K10plus-PPN:
  Universitätsbibliothek
• Lokale URL UB: Zum Volltext
• Lokale URL UB: Bibliothek der Medizinischen Fakultät Mannheim der Universität Heidelberg
• Bibliothek/Idn: UW / m4645476068
• Lokale URL Inst.: Zum Volltext

Abstract

-- Chapter 1 Introduction of MAFLD/MASLD. -- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC. -- Chapter 3 Decoding MAFLD’s pathophysiology. -- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage. -- Chapter 5 Diagnostic Advances in MAFLD/MASLD. -- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes. -- Chapter 7 MAFLD as a multisystemic disease. -- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship. -- Chapter 9 Current Standards in Therapeutic Management. -- Chapter 10 REVOLUTIONARY BREAKTHROUGHS. -- Chapter 11 Integrative Approaches to MAFLD/MASLD Management. -- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS. -- Chapter 13 Looking ahead. -- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.

Abstract

This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.